BOLOGNA, ITALY

— The agreement covers the countries of the European Union, the European Economic Area, the United Kingdom, Ukraine, Russia and the CIS — Bentracimab is a human monoclonal antibody fragment to counteract the antiplatelet effects of ticagrelor — After the recent acquisition of Lumeblue®, Alfasigma’s pipeline is enriched with a biotechnological drug Alfasigma has entered into […]

v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in DUBAI during the EXPO An innovative geo-localization software has being launched to increase knowledge & awareness […]

Online doctorAsyou, a web platform entirely dedicated to physicians The website optimizes research on the most important and autoritative medical databases such as Pubmed, ICTRP and ClinicalTrials.gov. An entirely new area presents online courses for physicians on several different topics Alfasigma has recently launched a number of digital activities that expand its web presence and […]